1. Home
  2. PHR vs OABI Comparison

PHR vs OABI Comparison

Compare PHR & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Phreesia Inc.

PHR

Phreesia Inc.

N/A

Current Price

$12.58

Market Cap

788.3M

ML Signal

N/A

Logo OmniAb Inc.

OABI

OmniAb Inc.

N/A

Current Price

$5.11

Market Cap

696.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PHR
OABI
Founded
2005
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
788.3M
696.4M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
PHR
OABI
Price
$12.58
$5.11
Analyst Decision
Buy
Strong Buy
Analyst Count
18
7
Target Price
★ $13.93
$8.33
AVG Volume (30 Days)
633.2K
★ 1.4M
Earning Date
12-07-2026
10-30-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 103.92
6.56
EPS
★ 0.08
N/A
Revenue
★ $480,591,000.00
$18,666,000.00
Revenue This Year
$7.32
$94.10
Revenue Next Year
$3.73
$30.33
P/E Ratio
$155.56
★ N/A
Revenue Growth
★ 14.48
N/A
52 Week Low
$7.77
$1.32
52 Week High
$23.31
$5.43

Technical Indicators

Market Signals
Indicator
PHR
OABI
Relative Strength Index (RSI) 69.00 56.98
Support Level $11.38 $4.51
Resistance Level $12.70 $5.06
Average True Range (ATR) 0.47 0.34
MACD 0.09 0.02
Stochastic Oscillator 89.79 64.93

Price Performance

Historical Comparison
PHR
OABI

About PHR Phreesia Inc.

Phreesia Inc is a provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes. Its platform is embedded directly into provider workflows and patient interactions, enabling healthcare organizations to activate patients, streamline administrative processes, and improve financial performance across the care continuum. The group serves a diverse group of healthcare organizations, including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest, and not-for-profit and other organizations.

About OABI OmniAb Inc.

OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.

Share on Social Networks: